SASSO, Ferdinando Carlo
 Distribuzione geografica
Continente #
EU - Europa 14.540
AS - Asia 5.674
NA - Nord America 5.527
SA - Sud America 1.016
AF - Africa 79
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 5
Totale 26.850
Nazione #
RU - Federazione Russa 9.812
US - Stati Uniti d'America 5.419
SG - Singapore 2.038
CN - Cina 1.403
IE - Irlanda 1.347
IT - Italia 1.095
HK - Hong Kong 935
BR - Brasile 856
DE - Germania 501
GB - Regno Unito 498
UA - Ucraina 407
VN - Vietnam 342
KR - Corea 297
IN - India 235
SE - Svezia 214
FR - Francia 178
FI - Finlandia 145
JP - Giappone 126
GR - Grecia 98
TR - Turchia 98
AR - Argentina 66
CA - Canada 53
NL - Olanda 53
AT - Austria 36
CZ - Repubblica Ceca 35
MX - Messico 35
ID - Indonesia 31
BD - Bangladesh 28
EC - Ecuador 26
BE - Belgio 24
ZA - Sudafrica 23
PL - Polonia 20
IQ - Iraq 19
VE - Venezuela 18
MA - Marocco 16
PK - Pakistan 16
CO - Colombia 15
ES - Italia 14
IR - Iran 13
UZ - Uzbekistan 12
DK - Danimarca 11
EG - Egitto 11
IL - Israele 11
LT - Lituania 10
PY - Paraguay 10
UY - Uruguay 10
CH - Svizzera 9
SC - Seychelles 9
AU - Australia 8
AE - Emirati Arabi Uniti 7
JO - Giordania 7
PE - Perù 7
AZ - Azerbaigian 6
CL - Cile 5
EU - Europa 5
GE - Georgia 5
PT - Portogallo 5
RO - Romania 5
TN - Tunisia 5
ET - Etiopia 4
JM - Giamaica 4
KG - Kirghizistan 4
LB - Libano 4
MY - Malesia 4
OM - Oman 4
TT - Trinidad e Tobago 4
BH - Bahrain 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
EE - Estonia 3
KE - Kenya 3
NG - Nigeria 3
NP - Nepal 3
RS - Serbia 3
SA - Arabia Saudita 3
TW - Taiwan 3
AL - Albania 2
AM - Armenia 2
BG - Bulgaria 2
BN - Brunei Darussalam 2
BO - Bolivia 2
HN - Honduras 2
HU - Ungheria 2
KW - Kuwait 2
KZ - Kazakistan 2
LA - Repubblica Popolare Democratica del Laos 2
LU - Lussemburgo 2
MO - Macao, regione amministrativa speciale della Cina 2
TJ - Tagikistan 2
AN - Antille olandesi 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CY - Cipro 1
DM - Dominica 1
GF - Guiana Francese 1
HR - Croazia 1
IS - Islanda 1
Totale 26.840
Città #
Moscow 3.525
Dublin 1.318
Hong Kong 925
Singapore 884
Santa Clara 756
Chandler 692
Jacksonville 622
Dallas 306
The Dalles 306
Hefei 291
Seoul 290
Naples 231
Bengaluru 189
Ashburn 181
Princeton 176
Beijing 173
New York 165
Medford 132
Munich 130
Ho Chi Minh City 126
Roxbury 121
Ann Arbor 108
Bremen 101
Boardman 90
Wilmington 82
São Paulo 78
Woodbridge 72
Caserta 69
Hanoi 67
San Mateo 65
Nanjing 63
Cambridge 54
Los Angeles 54
Des Moines 40
Aversa 34
Falkenstein 31
Amsterdam 30
Düsseldorf 29
Houston 29
Napoli 29
Rio de Janeiro 29
Salerno 29
Jinan 26
Milan 26
Mountain View 26
Tianjin 26
Brussels 24
Ercolano 24
Frankfurt am Main 21
Helsinki 21
Kunming 21
Nuremberg 21
Rome 19
Turku 19
Brooklyn 18
Changsha 18
Istanbul 18
Shenyang 18
Belo Horizonte 17
Brno 17
Haiphong 16
Shanghai 16
Boston 15
Brasília 15
London 15
Nanchang 15
Norwalk 15
Ottawa 15
Seattle 15
Vienna 15
Atlanta 14
Da Nang 14
Giugliano In Campania 14
Tokyo 14
Chicago 13
Lappeenranta 13
Montreal 13
Paris 13
Porto Alegre 13
Stockholm 13
Chennai 12
Florence 12
Guangzhou 12
Zhengzhou 12
Haikou 11
Redwood City 11
Salvador 11
Tashkent 11
Bari 10
Antea 9
Campinas 9
Lanzhou 9
Mexico City 9
Vitulazio 9
Bexley 8
Bologna 8
Curitiba 8
Dhaka 8
Dong Ket 8
Fairfield 8
Totale 13.583
Nome #
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events 294
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 205
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 188
Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes. 183
A Multicenter, Open-Label Phase II Study of Metformin With Erlotinib in Second-Line Therapy of Stage IV Non-Small-Cell Lung Cancer Patients: Treatment Rationale and Protocol Dynamics of the METAL Trial. 182
Endocan Serum Levels in Patients with Non-Alcoholic Fatty Liver Disease with or without Type 2 Diabetes Mellitus: A Pilot Study 174
Aminotrasferase activity and acarbose treatment in patients with type 2 diabetes 171
Acute effects of beta-endorphin on cardiovascular function in patients with mild to moderate chronic heart failure 169
Application and internal validation of lung ultrasound score in COVID-19 setting: The ECOVITA observational study 168
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 165
MiRNA regulation of the hyperproliferative phenotype of vascular smooth muscle cells in diabetes 159
Acute pressor and hormonal effects of beta-endorphin at high doses in healthy and hypertensive subjects: role of opioid receptor agonism. 158
[Surgical treatment and interventional therapy in cerebral ischemia] 158
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study 158
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 157
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 156
Carbonic anhydrase activation is associated with worsened pathological remodeling in human ischemic diabetic cardiomyopathy 154
Non-invasive respiratory support in SARS-CoV-2 related acute respiratory distress syndrome: when is it most appropriate to start treatment? 152
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 148
Effect of treatment with acarbose and insulin in patients with non-insulin-dependent diabetes mellitus associated with non-alcoholic liver cirrhosis 147
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 146
Activity and molecular targets of pioglitazone via blockade of proliferation, invasiveness and bioenergetics in human NSCLC 144
EFFECT OFTREATMENT WITH ACARBOSE,AN A-GLUCOSIDASE INHIBITOR ANDINSULIN IN PATIENT WITH NON-INSULIN-DEPENDENTDIABETESMELLITUS NON ALCOLIC LIVER CIRRHOSIS 143
Clopidogrel versus ticagrelor in high-bleeding risk patients presenting with acute coronary syndromes: insights from the multicenter START-ANTIPLATELET registry 142
Bipolar Patients and Bullous Pemphigoid after Risperidone Long-Acting Injectable: A Case Report and a Review of the Literature 142
esults from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study. 141
HBV Infection and Host Interactions: The Role in Viral Persistence and Oncogenesis 139
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 139
Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients 138
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 138
ULTRASOUND TIPS IN THE LUNG CANCER DIAGNOSIS: A PILOT STUDY 137
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 137
Cardiorenal Impact of SGLT-2 Inhibitors: A Conceptual Revolution in The Management of Type 2 Diabetes, Heart Failure and Chronic Kidney Disease 136
Factors affecting long-term changes of liver stiffness in direct-acting anti-hepatitis C virus therapy: a multicenter prospective study 135
Aminotransferase activity and acarbose treatment in patients with type 2 diabetes 134
Amelanotic metastatic melanoma of the stomach presenting with iron deficiency anemia 133
IMPACT OF TYPE II DIABETES ON HCC APPEARANCE IN PATIENTS TREATED WITH DIRECT ACTING ANTIVIRALS 131
Efficacy and safety of the sofosbuvir/velpatasvir combination for the treatment of patients with early mild to moderate COVID-19 131
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 130
[Inhibitors of the platelet's receptor GPIIb/IIIA. Progress in the treatment of acute myocardial ischemia and future trends] 129
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 128
Adapting the GLP-1-signaling system to the treatment of type 2 diabetes 128
Glucose metabolism and coronary heart disease in patients with normal glucose tolerance. 127
Pre-Menopausal Breast Fat Density Might Predict MACE During 10 Years of Follow-Up: The BRECARD Study 127
Can Metformin Exert as an Active Drug on Endothelial Dysfunction in Diabetic Subjects? 127
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 126
Effect of a single high-fat meal on endothelial function in patients with the metabolic syndrome: Role of tumor necrosis factor-alpha 126
Effects of stress hyperglicemia on acute myocardial infarction 126
Mortality and risk factors of vaccinated and unvaccinated COVID-19 frail patients treated with anti-SARS-CoV-2 monoclonal antibodies. A real-world study 124
Clinical application of lung ultrasound score on COVID-19 setting: a regional experience in Southern Italy 124
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 123
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts 122
Multi-detector row CT for depicting anatomic features of cephalothoracopagus varieties: revised approach 122
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 121
GLP-1 Receptor Agonists in Non-Alcoholic Fatty Liver Disease: Current Evidence and Future Perspectives 121
Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome 121
Cardiovascular benefits from gliflozins: Effects on endothelial function 121
Comment on: Effect of Vitamin D supplementation in patients with liver cirrhosis having spontaneous bacterial peritonitis: a randomized controlled study 121
Predictors of early and late hepatocellular carcinoma recurrence 120
Gender Differences in the Pathogenesis and Risk Factors of Hepatocellular Carcinoma 120
Effect of rosiglitazone on endothelial function and inflammatory markers in patients with the metabolic syndrome 120
A case of autoimmune polyglandular syndrome developed after interferon-alpha therapy 120
Natural history of hepatitis C virus carriers with persistently normal aminotransferase levels 119
Dipeptidyl peptidase 4 inhibition may facilitate healing of chronic foot ulcers in patients with type 2 diabetes. 119
Precoce evidenziazione della nefropatia diabetica mediante scìntigrafia renale con 99-Tc DTPA 119
The ubiquitin-proteasome system and inflammatory activity in diabetic atherosclerotic plaques: Effects of rosiglitazone treatment 119
Tight Glycemic Control May Increase Regenerative Potential of Myocardium during Acute Infarction. 118
Genetic predictors of response to treatment of chronic hepatitis C virus infection in patients from southern Italy 118
Metformin therapy effects on the expression of sodium-glucose cotransporter 2, leptin, and sirt6 levels in pericoronary fat excised from pre-diabetic patients with acute myocardial infarction 118
Blocco di branca sinistro in lavoratori sottoposti a movimentazione manuale di carichi con basso rischio di patologie cardiache: applicazione della tomografia computerizzata multistrato 117
Blocco di branca sinistra in lavoratori sottoposti a movimentazione manuale di carichi con basso rischio di patologie cardiache: applicazione della tomografia computerizzata multistrato 117
Pancreatic cancer and diabetes: A two-way relationship in the perspective of diabetologist 117
Autonomic nervous system dysfunction correlates with microvascular damage in systemic sclerosis patients 117
Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up 117
The possible role of the ubiquitin proteasome system in the development of atherosclerosis in diabetes 116
Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism. 116
Effects of insulin-glucose infusion on left ventricular function at rest and during dynamic exercise in healthy subjects and noninsulin dependent diabetic patients: a radionuclide ventriculographic study 116
Disfunzione renale nell’anziano: processo fisiologico o malattia? 116
Relevance of lung ultrasound in the diagnostic algorithm of respiratory diseases in a real-life setting: A multicentre prospective study 116
Effect of insulin on left ventricular function during dynamic exercise in overweight and obese subjects 116
HCC and molecular targeting therapies: Back to the future 116
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment 116
Impact of chronic liver disease on SARS-CoV-2 infection outcomes: Roles of stage, etiology and vaccination 115
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 115
Expression of angiogenic factors during acute coronary syndromes in human type 2 diabetes 114
High cardiovascular risk in patients with Type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort Study. 114
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 113
Sodium-Glucose Co-Transporters Family: Current Evidence, Clinical Applications and Perspectives 113
Very large abscesses of lower limbs by Nocardia farcinica requiring surgical management in patient with minimal change disease under chronic steroid treatment 113
Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients-a systematic review 113
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 112
An Update on Betrixaban, the Challenging Anticoagulant Agent for Extended Venous Thromboembolism Prophylaxis 112
Liver Involvement in Patients With Systemic Sclerosis: Role of Transient Elastography in the Assessment of Hepatic Fibrosis and Steatosis 112
LOWERing the INtensity of oral anticoaGulant Therapy in patients with bileaflet mechanical aortic valve replacement: results from the "LOWERING-IT" Trial. 112
A case of anaplastic thyroid carcinoma with exceptional growth. 111
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy 111
effect of treatment with acarbose and insulin inpatients with non-insulin-dependent diabetes mellitus associated with non-alcolic liver cirrhosis. 110
Effect of Body Mass Index on Ischemic and Bleeding Events in Patients Presenting With Acute Coronary Syndromes (from the START-ANTIPLATELET Registry) 110
Regression of carotid atherosclerosis by control of morning blood pressure peak in newly diagnosed hypertensive patients 109
Conversion from Epoetin and Darbepoetin to C.E.R.A. in Non-Dialysis CKD Patients: A Multicenter Italian Prospective Study in Nephrology Practice. 108
Totale 13.266
Categoria #
all - tutte 93.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 93.779


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021602 0 0 0 0 0 19 154 100 18 125 135 51
2021/20221.326 94 11 28 60 421 29 32 36 70 108 108 329
2022/20232.682 222 75 62 213 291 225 12 164 1.255 44 58 61
2023/20241.450 117 77 74 129 377 170 21 50 19 71 123 222
2024/20254.354 45 85 37 115 640 477 627 377 689 478 398 386
2025/202614.576 826 1.064 1.111 819 1.597 9.159 0 0 0 0 0 0
Totale 27.348